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Abstract
Patients with sickle cell disease (SCD) utilize the emergency department (ED) frequently
due to limited access to adult health care providers. Few providers are knowledgeable
about caring for patients with sickle cell disease. This quantitative study’s purpose and
research questions addressed whether there was a correlation between ED utilization and
ED length of stay (LOS) pre- and post-enrollment in an adult comprehensive sickle cell
clinic between the years of 2012 and 2017. The Donabedian framework was used to
examine the structure, process, and outcomes related to the benefits of care in a sickle
cell center. The independent variables of pre- and post-enrollment of patients in a sickle
cell specialty center in relation to the dependent variables of ED utilization and ED LOS
were analyzed using a chi-square test and a paired sample t test, and age was measured as
a covariate using linear regression. Results indicated a significant difference in ED
utilization between the pre- and post-enrollment groups, with an increased ED utilization
in the pre-enrollment group compared to patients enrolled in the SCD clinic group. There
was no statistical significance for ED LOS in the pre-enrollment group compared to the
post-enrollment group. Results also indicated a significant correlation between ED
utilization and age, but no significant correlation between ED LOS and age. The positive
social change benefits of this study include the advantage of specialty clinics for SCD
patients to prevent ED admissions because of improvements in care, the importance of
SCD specialty clinics for different regions, and the role health care administrators have
with implementing policies for these clinics.
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Section 1: Foundation of the Study and Literature Review
The lack of sickle cell providers has been highlighted as one of the factors that
affects emergency department (ED) utilization in adult patients with sickle cell disease
(Ogu & Billet, 2018). The literature showed a gap regarding the administrative benefits,
such as ED utilization and ED length of stay (LOS), of comprehensive sickle cell clinics.
ED utilization is defined as the use of the ED department by SCD patients, and ED LOS
is defined as the amount of time from the patient checking in to the ED to discharge from
the ED or admission to the hospital. Unnecessary utilization of the ED could increase
health care costs (Enard & Ganeline, 2013).
National estimates of SCD-related ED visits in the United States were $2.96
million (Lankzkron et al., 2010), and annual health care expenditure for SCD
hospitalizations was over $900 million (Shah et al., 2019). ED utilization and LOS are
important considerations for hospital administrators because unnecessary ED utilization
can increase the overall cost of care and duplication of services, which can further burden
hospitals (Ho et al., 2017).
The current study addressed ED utilization and ED LOS of patients who used the
ED in the hospital system prior to attending an adult sickle cell center (pre-enrollment)
and after attending an adult sickle cell center (post-enrollment). This study’s dependent
variables included ED utilization and ED LOS, and the independent variables included
pre-enrollment and post-enrollment.
The information from this study could help providers understand and appreciate
the best standard of care for SCD patients, which could translate into cost reduction for
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health care systems. This study may also increase the understanding of the benefits for
sickle cell patients when they attend comprehensive sickle cell centers, including how
comprehensive sickle cell centers affect the ED utilization and LOS. In turn, this study
may motivate hospital administrators to invest in sickle cell clinics.
Problem Statement
Caring for adult SCD patients is challenging due to limited adult providers who
are educated in SCD (Ogu & Billet, 2018). Limited data are available on the effectiveness
of adult comprehensive sickle cell clinics. Some studies suggested an increase in ED
utilization when patients attend sickle cell centers, and some studies suggested a decrease
in ED utilization when patients attend sickle cell centers (Artz et al., 2010; Binding et al.,
2014; Smeltzer et al., 2016.) The problem was the evidence was not conclusive regarding
the ED utilization patterns of patients who attend a comprehensive sickle cell center.
Previous studies indicated adult patients with SCD received fragmented care due to a lack
of specialized teams devoted to adult SCD (Ogu & Billet, 2018; Reich et al., 2019; TerMinassian et al., 2019). In a national study, primary care physicians did not feel
comfortable treating SCD because they did not have enough education about SCD to
understand the needs of these patients (Mainous et al., 2015). Due to the lack of sickle
cell providers, there was limited evidence regarding the administrative benefits, such as
ED utilization and ED LOS, among adult sickle cell patients who receive care in sickle
cell centers. The limited evidence that did exist was inconclusive. In the current study, I
compared the administrative outcomes that affect medical costs, such as ED utilization
and ED LOS of adult SCD patients. The purpose of this quantitative study was to
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examine the correlation in ED utilization and ED LOS among adult sickle cell patients
who received care at an adult sickle cell center in Tennessee. The patients’ ED utilization
and ED LOS were compared from pre-enrollment to the center and post-enrollment to the
center between the years of 2012 and 2017. Pre-enrollment was defined as prior to being
a patient of the adult sickle cell center, and post-enrollment was defined as after being a
patient of the adult sickle cell center.
Smeltzer et al. (2016) looked at a pediatric comprehensive sickle cell center and
found that hospitalizations and clinic visits increased when the sickle cell center was
located closer to the patient, suggesting that sickle cell patients who lived further away
from a center may have inadequate medical care and access to care. Smeltzer et al.
suggested the decrease in hospitalizations and clinic visits for patients who lived farther
away from the comprehensive sickle cell center could be related to underreporting ED
and inpatient utilization in other medical facilities closer to the patients’ homes.
However, Smeltzer et al. also found that patients’ overall ED utilization rate was lower
than the national averages for the pediatric SCD population.
Binding et al. (2014) investigated how sickle centers in high and low disease
prevalence areas tended to show a reduction of admission rates, but the study included
only a small sample size and was not designed to consider the ED utilization and LOS
with SCD centers. The literature on whether sickle cell clinics reduce hospital and ED
utilization was mixed and inconclusive. Some researchers found that using a
multidisciplinary approach decreased ED utilization and using a SCD center reduced
hospital inpatient admission rates (Blinder et al., 2015; Powell et al., 2016; Simpson et
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al., 2017), while Smeltzer et al. (2016) suggested that the closer a patient lives to the ED
or center, the ED utilization increases.
The data for the current study were obtained from a sickle cell center that
provides multidisciplinary care and individualized pain plans based on the best standard
of care, and hematologists specialized in treating SCD. The multidisciplinary approach at
the center includes weekly team meetings between different health providers such as
medical doctors from adult and pediatric hematology, ED providers, and primary care;
nurse practitioners; and other ancillary health care staff such as nurses, social workers,
and case managers. The results of this study may help administrators understand the
benefits of sickle cell patients attending comprehensive sickle cell centers, including
understanding how comprehensive sickle cell centers affect ED utilization and LOS. In
turn, this study may motivate hospital administrators to invest in sickle cell clinics to help
reduce the total cost of care. Hospital revenue in the ED is tied to improving performance
metrics such as ED wait times, patients leaving without being seen, ED LOS, decisions to
admit, and patient satisfaction (Feinberg & Stone-Griffith, 2016).
Purpose of the Study
The purpose of this quantitative study was to determine whether there was a
correlation in ED utilization and ED LOS among adult sickle cell patients who received
care at an adult sickle cell center, pre- and post-enrollment to the clinic, between the
years of 2012 and 2017. ED utilization and LOS are important considerations for hospital
administration because unnecessary ED utilization can increase the overall cost of care
and duplication of services, which can further burden the hospitals (Ho et al., 2017).
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When the ED LOS is long, there is one less ED bed available to another patient, which
directly impacts the hospital’s revenue (Feinberg & Stone- Griffith, 2016). It is in the
best interest of hospital administrators to pay careful attention to ED optimization to
improve performance and quality measures (Feinberg & Stone-Griffith, 2016). Hospitals
are under regulatory pressure to reduce ED costs, improve efficiency, and increase
throughput capacity, which then ties to hospital reimbursement. The current study would
help determine administrative benefits of sickle cell centers.
The independent variables included pre- and post-enrollment to the sickle cell
center. The dependent variables included ED utilization (frequency of ED visits) and ED
LOS. The study addressed the dependent variables of the same patients with SCD prior to
being enrolled into the sickle cell specialty center (pre-enrollment) and after being
enrolled to the center (post-enrollment) to determine whether there was a statistical
difference in ED LOS. The results of this study may provide insight regarding the
benefits of providing specialized SCD care, which may include lower ED utilization,
lower LOS, improved quality of care, and lower cost of care. The study may help health
care leaders determine the usefulness of sickle cell clinics and may help administrators
determine the benefits of investing in more comprehensive sickle cell centers.
ED utilization and LOS are important considerations for hospital administration
because unnecessary ED utilization can increase the overall cost of care and duplication
of services, such as repeating labs or diagnostics that could be performed as an outpatient
instead, which can further burden the hospitals (Ho et al., 2017). It is in the best interest
of hospital administrators to pay careful attention to ED optimization to improve
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performance and quality measures (Feinberg & Stone-Griffith, 2016). Feinberg and
Stone-Griffith (2016) stated that hospitals are under regulatory pressure to reduce ED
costs, improve efficiency, and increase throughput capacity, which then ties to hospital
reimbursement.
Adult sickle cell patients tend to utilize the ED or have increased inpatient
admissions secondary to SCD-related complications (Chappidi et al., 2013; Cline et al.,
2018; Glassberg, 2012). The increased complications may be related to the lack of sickle
cell clinics and providers. The findings from this research may contribute to positive
social change for the sickle cell community by increasing accessibility to comprehensive
sickle cell centers, which may afford patients the opportunity to receive the best
evidence-based care. Additionally, this study may encourage increased funding for sickle
cell clinics or sickle cell providers by providing administrative insights into the optimal
care of patients with SCD.
Research Questions and Hypotheses
RQ1: Is there a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017?
Ho1: There is no statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.

7
Ha1: There is a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.
RQ2: Is there a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017?
Ho2: There is no statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
Ha2: There is a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
RQ3: Is there a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho3: There is no correlation between ED utilization and age among adult sickle
cell patients in patients between the years of 2012 and 2017.
Ha3: There is a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
RQ4: Is there a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho4: There is no correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
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Ha4: There is a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
Theoretical Foundation of the Study
I used the Donabedian (1985) framework to examine the structure, process, and
outcomes of attending a sickle cell center. The model provided a foundation for
understanding whether the effectiveness of an adult sickle cell center reduces the use of
the ED. The Donabedian framework includes three categories: structure, process, and
outcome. The structure provides a model for determining how care is organized, the
process determines what is known to be the best evidence-based medical care, and the
outcome emphasizes the quality measures that affect the end result of care (Donabedian,
1985; Van Houdt et al., 2013). The Donabedian framework related to the current study in
the following ways: The structure was the comprehensive sickle cell clinic; the process
was the best practice standards already researched in sickle cell, which included
multidisciplinary care and individualized care plans; and the outcome related to the use of
ED utilization and LOS in the ED (see Figure 1).
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Figure 1
Three Stages of the Donabedian Framework

Nature of the Study
The study had a retrospective correlational quantitative design. The independent
variables were pre- and post-enrollment to the center, and the dependent variables were
ED utilization and ED LOS. A chi-square test, a paired sample t test, and a linear
regression analysis were used to compare the pre- and post-enrollment groups; linear
regression was used to compare groups in relation to age.
I used a secondary data set collected by the former medical director of an adult
sickle cell clinic in a southern U.S. state. The data set was a convenience sample to
investigate the effectiveness of an adult sickle cell clinic related to ED utilization. The
data set included data on all patients who came to the ED through a large hospital system
in Tennessee and were diagnosed with SCD for the time frame of 2012 to 2017.
Permission to access the secondary data set was obtained by completing the Collaborative
Institutional Training Initiative (CITI) training and submitting a request to the
organization’s institutional review board (IRB) committee.
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Each patient was counted as a unique patient, each visit was counted as an
encounter, and patients may have had more than one encounter. The ED patient list was
cross-referenced with the sickle cell center’s list of patients to determine whether the
patient attended the adult center and when the patient was first enrolled in the clinic. The
data set also included the inpatient (IP) utilization, the LOS, the insurance carrier, and
demographic information. All of the secondary data were de-identified, and no personal
information was known to me.
Literature Search Strategy
To better understand the association between ED utilization and ED LOS in the
sickle cell population, several databases were used to retrieve the most current literature
on ED utilization in SCD, ED LOS in SCD, and factors that affect SCD ED utilization.
Selected articles relating to the care of patients with SCD and outcomes such as ED
utilization and ED LOS were identified. The keywords searched were sickle cell disease,
inpatient (IP) utilization, ED utilization, and comprehensive sickle cell centers. Database
searches were my primary means of searching for related articles. The following Walden
University databases and search engines were used: EBSCO, Medline, PubMed, and the
Thoreau multi database search. The search was focused initially on ages 18 years and
older, but limited data existed in the adult population, so the search was expanded to
include the pediatric population as well. The publication dates for scholarly articles
ranged from 2009 to 2018.
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Literature Review Related to Key Variables and/ or Concepts
The purpose of the literature review was to synthesize studies completed by
researchers about ED utilization and ED LOS (the dependent variables) in SCD patients,
and enrollment in a comprehensive sickle cell center (the independent variable). The
literature review is divided into the following sections: (a) the general overview of SCD,
(b) the typical barriers that adult sickle cell patients face, (c) the factors that affect ED
utilization and LOS in adult sickle cell patients, and (d) current evidence on sickle cell
centers.
General Overview of SCD
SCD is a group of inherited red blood cell disorders that can lead to multiple
complications to the patient, such as vaso-occlusive pain crises and acute chest syndrome
(Bojanowski, 2010). SCD results in hemolytic anemia and small vessels’ blockade, which
can lead to vaso-occlusive episodes and/or organ failure (Shah et al., 2019). The blockage
of blood vessels can cause the following complications: acute chest syndrome secondary
to sickling of blood vessels of the lungs; acute pain crises, also known as vaso-occlusive
pain crises, which is caused secondary to sickled blood flow and deoxygenated blood;
brain complications such as strokes; and heart problems such as ischemic heart disease
and pulmonary hypertension (Lee et al., 2019; National Heart, Lung, and Blood Institute,
n.d.; Shah et al., 2019). The sickle cell complications cause sickle cell patients to have
increased hospitalizations and to frequently utilize the ED (Hemker et al., 2011).
Approximately 85% of the SCD-related ED visits had vaso-occlusive crises as the
primary reason for admission, and the other 15% of the ED visits contributed to SCD
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complications (Blinder et al., 2015). The other most common complications included
infectious and parasitic disease and cerebrovascular complications such as seizures and
strokes (Shah et al., 2019). Other sickle cell complications included splenic crises, which
can lead to immunocompromise, gallstone, and priapism in males (Carden et al., 2016).
SCD is a disease that affects fewer than 200,000 people nationwide, and
consequently the disease does not receive much research funding (Lee et al., 2019).
People living with SCD have limited access to comprehensive care because providers do
not have enough education/comfort to treat the disease (Mainous et al., 2015) and
therefore have more difficulty managing patients’ pain (Lee et al., 2019). When the sickle
cell pain cannot be managed at home, ED utilization is increased (Smeltzer et al., 2016).
Soboto (2011) performed a survey of 30 pediatric SCD centers and found that only 18
centers transitioned their patients to adult hematologists specializing in SCD. The
mortality rates of young adults who were transitioning with SCD increased by two- to
threefold (Hamideh & Alvarez, 2013).
Typical Barriers That Adult SCD Patients Face
SCD has limited research funding because there is a limited number of patients
diagnosed with this illness (Lee et al., 2019). Limited research has shown a lack of
educated providers in the SCD adult population (Mainous et al., 2015). The lack of health
care providers in SCD adult care has been demonstrated in the overutilization of EDs for
SCD care due to lack of access to care (Blinder et al., 2015; Ogu & Billet, 2018; Smeltzer
et al., 2018; Ter-Minassian et al., 2019). Decreased adherence to health maintenance
visits, such as regular checkups and regular assessment of blood levels, was noted more
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among patients without private insurance, possibly related to health literacy, economic
status, and access to health care issues (Smeltzer et al., 2016).
Other barriers that adult SCD patients face is decreased access to health care, such
as the unsuccessful transition of pediatric patients to adult sickle cell care, and increased
distance from a sickle cell center to the patient’s house (Smeltzer et al., 2016). Other
barriers include low socioeconomic status (Cronin et al., 2018; Smeltzer et al., 2016) and
having private insurance versus Medicaid (Amendah et al., 2010; Cronin et al., 2018;
Smeltzer et al., 2016). Age and fragmented care are also documented barriers to caring
for the sickle cell patient (Blinder et al., 2015; Smeltzer et al., 2016).
Children who have SCD received adequate standardized care, but the patients
who reach adulthood did not receive the same care due to a lack of providers (TerMinassian et al., 2019). Patients with high ED reliance incurred more days in the hospital
and significantly higher health care costs (Blinder et al., 2015). SCD patients who
transition from youth to adulthood have difficulty finding an adult provider devoted to
SCD care (Ter-Minassian et al., 2019). Total costs per patient per month were lower for
pediatric patients compared with adult patients due to fragmented care (Kauf et al., 2009).
Adults comprised 75% of the SCD hospital admissions (Artz et al., 2010). Cronin et al.
(2018) reported that financial security, health literacy, spirituality, and lacking cues to
action like reminders were also perceived as barriers to sickle cell care. The current study
addressed access to care by determining whether the comprehensive sickle cell specialty
clinic affected the ED utilization and LOS before and after patients enrolled in the center.
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Factors That Affect ED Utilization and LOS in Adult SCD Patients
Sickle cell patients face multiple barriers that make optimal management of their
sickle cell disease difficult (Gray et al., 2018; Smelter et al., 2015). The challenges of
sickle cell care contribute to poor sickle cell outcomes, increased utilization of the ED,
increased hospitalizations, and increased cost of care (Blinder et al., 2015; Carden et al.,
2016; Smeltzer et al., 2016). Carden et al. (2016) reported that increased disease-specific
knowledge increased ED utilization as patients became more aware of SCD
complications. Alternatively, other research suggested that health literacy and education
affected ED utilization (Aisiku et al., 2009; Cronin et al., 2018). Age and disease severity
have also been shown to increase ED utilization (Aisiku et al., 2009; Blinder et al., 2015).
Multiple researchers found a common barrier was fragmented care or decreased providers
specialized in treating the adult sickle cell patient (Blinder et al., 2015; Ogu & Billet,
2018; Ter-Minassian et al., 2019). Multiple studies suggested that a multidisciplinary
approach to sickle cell care reduced ED utilization (Powell et al., 2016; Simpson et al.,
2017).
Sickle Cell Centers
Fragmented care is a major barrier to adult sickle cell care (Blinder et al., 2015;
Koch et al., 2014; Ogu & Billet, 2018; Ter-Minassian et al., 2019). The evidence
regarding the correlation between ED utilization and comprehensive sickle cell centers
was mixed and limited (Blinder et al., 2015; Powell et al., 2016; Simpson et al., 2017;
Smeltzer et al., 2016). Lavelle et al. (2018) found that Federally Qualified Health Centers
that provide comprehensive care increased ED utilization but decreased the number of
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outpatient clinic visits; however, when the analysis was adjusted for the case-mix, the
difference was attenuated. Similarly, patients who had more disease-specific knowledge,
which is a type of learning that empowers caregivers and patients to make life-changing
decisions, ED utilization increased as patients were more empowered of knowing their
disease and when they needed to utilize the ED; comprehensive multidisciplinary centers
are known to provide disease-specific knowledge (Carden et al., 2016). Alternatively,
Blinder et al. (2015) found that ED reliance increased among post-transition patients and
continued into adulthood secondary to decreased health care access once patients became
adults. Similarly, Simpson et al. (2017) found that sickle cell centers that provided best
practice advisories, an ED protocol, and a medical home, which is a method of providing
comprehensive and continuous care to adults with an emphasis of care coordination and
communication among high or super-utilizers, showed a tendency to decrease ED
utilization and LOS; however, the sample size for this study was small and included only
super-utilizers.
Simpson et al. (2017) and Powell et al. (2016) provided information on how a
multidisciplinary approach affected ED utilization in the sickle cell population. The
researchers found that monthly meetings, best practice advisories, and ED protocols
helped to decrease ED visits, ED LOS, IP admissions, and IP LOS. The practices of
monthly meetings, individualized pain plans for ED protocols, and best practice
advisories are consistent with comprehensive sickle cell clinics’ practices.
ED utilization for SCD patients was shown to be lower when a multidisciplinary
approach was used, which included monthly team meetings and development of
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individualized care plans (Powell et al., 2016; Simpson et al., 2017). Adult sickle cell
centers used a multidisciplinary approach to care, and Powell et al. (2016) and Simpson
et al. (2017) demonstrated that a multidisciplinary approach reduces ED utilization;
however, there was a gap in the literature regarding whether a relationship exists between
attending a comprehensive sickle cell center and ED utilization. Patients with SCD tend
to utilize ED services more than clinic services due to the lack of sickle cell providers
(Blinder et al., 2015). Cline et al. (2018) suggested alternative venues to manage
uncomplicated vaso-occlusive crises such as day hospitals or ED observation units to
decrease hospital admissions.
Smeltzer et al. (2016) found that the greater the distance between the
comprehensive sickle cell clinic and the patient’s house, the lower the ED utilization.
Smeltzer et al. reported that patients who lived further away from a sickle cell center
sometimes forego medical care. Smeltzer et al. also found that patients living within 35
miles of the hospital had 1.75 times the rate of hospitalization than those living 35 or
more miles away. The results of this study indicated that the closer a patient lives to the
hospital, the greater the ED utilization and hospitalizations, and therefore the greater the
cost. However, Smeltzer et al. attributed this to underreporting of patients who lived
farther away. Smeltzer et al. also found that hospitalizations and ED utilization rates in
their multidisciplinary clinic were significantly lower than the national averages.
Binding et al. (2014) found that sickle cell centers with a lower prevalence of
sickle cell population had similar ED visits and hospital admissions compared to sickle
cell centers with a higher prevalence of sickle cell population. Artz et al. (2010) found a
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downward trend in admissions, 30-day readmissions, and LOS after the establishment of
a multidisciplinary sickle cell center. Both these studies showed mixed reviews of sickle
cell centers’ administrative benefits, therefore demonstrating a gap in the literature.
Comprehensive sickle cell clinics provide multidisciplinary care and
individualized care plans that improve patient outcomes (Powell et al., 2016). Adult
sickle cell patients have multiple complications, including vaso-occlusive pain crises and
acute chest syndrome, which can increase ED utilization and hospitalizations (Blinder et
al., 2015; Carden et al., 2016; Hemker et al., 2011). Most ED visits by adult SCD patients
are due to a vaso-occlusive pain crisis; when the pain is not adequately addressed, it leads
to a hospitalization (Blinder et al., 2015).
Literature Review Conclusion
The research findings regarding the correlation between comprehensive sickle cell
centers and ED utilization are mixed, with some studies suggesting increased ED
utilization (Carden et al., 2016; Lavelle et al., 2018; Smeltzer et al., 2016) and other
studies suggesting decreased ED utilization (Powell et al., 2016; Simpson et al., 2017).
The current study was conducted to determine the relationship between ED utilization
and pre- and post-enrollment at a comprehensive sickle cell center. The literature did not
indicate whether there are benefits for adults who attend comprehensive sickle cell
centers with use of the ED.
Definitions
Best practice advisories: Evidence-based recommendations based on best
practices (Simpson et al., 2017).
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Comprehensive sickle cell clinic: A clinic that specializes in the care of adult
sickle cell patients by using a multidisciplinary approach, which may include monthly
team meetings and development of individualized care plans (Powell et al., 2016;
Simpson et al., 2017).
Disease-specific knowledge: This type of learning empowers principal caregivers
of children to make life-changing decisions that can be measured by behavior change
over time (Carden et al., 2016).
ED (emergency department) utilization: Emergency department utilization by
sickle cell patients. ED utilization was calculated by total use, called ED total and those
visits that did not result in an admission, called ED independent (Epstein et al., 2006).
ED LOS (emergency department length of stay): The amount of time from
checking into the ED to the discharge from the ED or admission to the hospital.
Fragmented care: When sickle cell patients transition from pediatric to adult care,
their medical care is interrupted, which can then result in poorer clinical outcomes
secondary to inconsistent and inadequate access to care (Blinder et al., 2015; Koch et al.,
2014).
Health literacy: The degree to which individuals have the capacity to obtain,
process, and understand basic health information and services needed to make
appropriate health decisions (Carden et al., 2016).
Post-enrollment: A patient’s ED utilization and ED LOS after attending the adult
sickle cell center.
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Pre-enrollment: A patient’s ED utilization and ED LOS before attending the adult
sickle cell center.
SCD (sickle cell disease): A group of inherited disorders of red blood cells in
which abnormal hemoglobin is produced (Epstein et al., 2007).
Transition: This is the phase when a young adult receives uninterrupted,
developmentally appropriate medical care (Gray et al., 2018).
Vaso-occlusive crises: These are also referred to as pain crises, which are a
blockade of vessels secondary to sickled blood flow (Bojanowski, 2010; Lee et al., 2019).
Assumptions
It was important to acknowledge the assumptions that affected this study. I
assumed that patients only went to the ED based on where the data for this study were
collected. If a patient visited another ED, the information was not included in the
secondary data. The study did not account for the ED utilization at other health care
systems. The final assumption was that patients who attended the adult sickle cell clinic
chose the associated health care hospital as their medical home.
Scope and Delimitation, and Limitations
The scope of the study concerned the methodology, which was quantitative and
correlational with conclusions derived from a secondary data set. The previous medical
director created this secondary data set at an adult sickle cell clinic, and the information
technology analyst provided access to the data. The data set included data for all patients
who had a primary diagnosis of SCD and had come to the ED through the health care
system associated with the sickle cell center. Each patient visit was considered an
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encounter, and each encounter was determined to be either pre-enrollment to the center or
post-enrollment to the center. Additionally, the data set included the frequency of
utilization, the LOS, the insurance carrier, demographic information, utilization before
the center was established, and utilization after the center was established.
Permission to access the data set was accomplished by completing the CITI
training and communicating with the organization’s IRB. The independent variables that
were analyzed in this study included pre-enrollment to the center and post-enrollment to
the center, and the dependent variables included ED utilization and ED LOS. The study
did not account for other factors that may have affected the results such as demographics,
disease severity, distance from the patient’s house to the ED, and insurance carriers.
The study was limited to data of patients who came to the ED through the hospital
system associated with the adult sickle cell center in Tennessee. This meant that the
results may not be generalizable to the entire sickle cell population. In addition, I did not
consider sickle cell patients who received care at other sickle cell centers.
Significance, Summary, and Conclusions
The study’s results may provide insight regarding the benefits of specialized SCD
care, which may include lower ED utilization and lower LOS. In return, this could
improve the quality of care while potentially lowering the cost of care. The study may
help health care leaders determine the usefulness of sickle cell clinics and whether it is
effective to invest in more comprehensive sickle cell centers.
Adult sickle cell patients tend to utilize the ED or have increased IP admissions
secondary to SCD-related complications (Chappidi et al., 2013; Cline et al., 2018). The
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increased number of complications may be related to the lack of sickle cell
clinics/providers. The current findings may contribute to positive social change for the
sickle cell community, sickle cell clinics, and sickle cell providers by providing standards
and administrative insight into the optimal care of patients with SCD.
The gap in the literature pertained to how ED utilization correlated to attending a
sickle cell center. The literature showed mixed findings related to sickle cell clinics and
ED utilization. One study suggested an increase in utilization when the distance from the
patient’s house to the center was closer (Smeltzer et al., 2016). Other studies suggested a
decrease in ED utilization when receiving care at a sickle cell center (Powell et al., 2016;
Simpson et al., 2017). The current study may allow researchers, administrators, and
medical teams to determine how ED utilization may be affected when patients attend a
comprehensive sickle cell center. Section 2 provides information regarding the research
design and data collection methods for this study.
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Section 2: Research Design and Data Collection
In the previous section, I provided an extensive review of the current literature
related to ED utilization and LOS in the sickle cell patients and the literature related to
the benefits of comprehensive sickle cell centers in the adult sickle cell population.
Although multiple researchers have explored the benefits of sickle cell centers among the
pediatric sickle cell population, the research among the adult sickle cell population has
been mixed. My study addressed the administrative outcome of ED utilization and ED
LOS in an adult sickle cell clinic.
The purpose of this quantitative study was to examine the correlation in ED
utilization and LOS among adult sickle cell patients who received care at the adult
comprehensive sickle cell clinic pre- and post-enrollment to the center, between the years
of 2012 and 2017. The ED LOS is directly related to how many ED beds are available to
treat a patient, which affects hospital reimbursement; ED utilization is related to ED
optimization to improve performance and quality measures, which also improves
reimbursement (Feinberg & Stone-Griffith, 2016). The independent variables were preand post-enrollment to the sickle cell center, and the dependent variables were ED
utilization (the frequency of ED visits) and ED LOS. This section includes the research
design, methodology, threats to validity, and a summary.
Research Design and Rationale
The dependent variables were ED utilization and ED LOS, and the independent
variables were the pre- and post-enrollment to the adult sickle cell center. The research
design was retrospective, correlational, and quantitative. A chi-square test and a paired
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sample t test were used to compare ED utilization and ED LOS in the pre- and postenrollment group, and a regression analysis was used to compare age to ED utilization
and ED LOS. The design choice included a secondary data set to compare pre- and postenrollment, which required me to have IRB approval prior to accessing the data set at the
organization providing the data. This data approval process was time-consuming and took
2 months. Another constraint with this design choice was that the data set included data
collected from 2012 to 2017, meaning the data set was not the most current. However,
this design was the most appropriate for this study, and matched previous studies that
compared pre- and post-enrollment data.
Powell et al. (2018) used a retrospective study of unplanned acute care use (ED
and IP admissions) pre- and post-initiation of a multidisciplinary care team intervention
in a single urban academic health center in Pennsylvania. Simpson et al. (2016) also used
a retrospective pre- and post-implementation design; however, this study included only
10 subjects. The study by Ter-Minassian et al. (2019) was a retrospective cross-sectional
design that addressed yearly screening labs, hydroxyurea adherence, and documented
vaccinations.
Methodology
Study Population
The target population for the current study was adult sickle cell patients age 18
years or older who received services at the emergency rooms of the hospital system
associated with the adult sickle cell clinic. A total of 428 encounters of patients who went
to the ED were examined, including the pre- and post-enrollment groups.

24
Sampling and Sampling Procedures
The secondary data set that was used in this study was previously collected by the
health care system. The sampling strategy used for the original data was convenience
sampling. The secondary data set that I used included de-identified information and did
not include the patients’ name, date of birth, medical record number, address, zip codes,
or social security numbers. The letter of approval to access the data set was included in
the appendix along with a copy of the organization’s IRB approval. The data set was
saved on my personal laptop that was password protected.
The data set included data on all the patients who came to the ED through the
health care system associated with the sickle cell clinic who had a diagnosis of SCD.
Each patient visit was considered an encounter, and each encounter was determined to be
either pre-enrollment to the clinic or post-enrollment to the clinic. Additionally, the data
set included the frequency of utilization, the LOS, the insurance carrier, demographic
information, the utilization before the center was established, and the utilization after the
center was established. The inclusion criteria included adult sickle cell patients age 18
years or older who were enrolled in the adult sickle cell center for the years 2012 through
2017. The exclusion criteria included any sickle cell patients younger than 18 years of
age.
Power Analysis
The power analysis tool used was the G*Power, a free power analysis tool (Faul
et al., 2007). Based on the power analysis, the required sample size for the logistic
regression analysis was 84 (power = 0.80, alpha = 0.05, and predicted moderate effect
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size = 0.3). The analysis used was a priori logistic regression. The power and the alpha
level used were standard numbers that are typically used. The effect size that was used
was a moderate effect size (see Figure 2).
Figure 2
Power Analysis

Instrumentation and Operationalization of Constructs
The secondary data set was obtained from a large sickle cell center. Permission to
use this data set was received by both creators of the data via email communication. The
IRB program at the organization received my request to use the data, and my name was
added to access the data set. The data set included data on all patients who came to the
ED through the health care system associated with the clinic who had a diagnosis of SCD
from the years 2012 to 2017. Each patient visit was considered an encounter, and each
encounter was determined to be either pre-enrollment to the center or post-enrollment to
the center. Additionally, the data set included the frequency of utilization, the LOS, the
insurance carrier, demographic information, the utilization before the center was
established, and the utilization after the center was established. The data were tested for
accuracy by the IT systems analyst using sample patients. I looked at the ED utilization
prior to being enrolled in the adult center and after being enrolled in the center.
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The independent variables included the pre-enrollment to the adult sickle cell
center, which was coded as 1, and post-enrollment to the adult sickle cell center, which
was coded as 2. The ED utilization was measured by looking at the number of check-ins
a patient made to an ED in the health care system associated with the sickle cell clinic,
and the ED LOS was measured from the time a patient checked in to the ED to the time
the patient was discharged from the ED. I looked at the pre-enrollment ED utilization,
pre-enrollment ED LOS, post-enrollment ED utilization, and post-enrollment ED LOS.
Table 1 includes a description of the variables.
Table 1
Description of Variables
Independent variables
Pre-enrollment to the
adult sickle cell center
Post-enrollment to the
adult sickle cell center

Dependent variables
ED utilization

Covariates
Age

ED LOS

Age

Data Analysis Plan
I analyzed data from the secondary data set using the Statistical Package for the
Social Sciences (SPSS) Version 25. The pre-enrollment to the clinic group was coded as
a 1, and the post-enrollment to the clinic was coded as 2. Additionally, if the patient had
an ED visit, the encounter was coded as 1; other visit types were coded as 0.

Research Questions and Hypotheses
RQ1: Is there a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017?
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Ho1: There is no statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.
Ha1: There is a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.
RQ2: Is there a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017?
Ho2: There is no statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
Ha2: There is a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
RQ3: Is there a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho3: There is no correlation between ED utilization and age among adult sickle
cell patients in patients between the years of 2012 and 2017.
Ha3: There is a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
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RQ4: Is there a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho4: There is no correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
Ha4: There is a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.

Detailed Analysis Plan
The research was a retrospective correlational quantitative design. The
independent variables were pre- and post-enrollment to the center, and the dependent
variables were ED utilization and ED LOS. Using SPSS Version 25, I compared the preand post-enrollment group using a chi-square test and a paired sample t test, and I
compared the covariate of age using linear regression. Multiple studies suggested that the
use of the ED increases with age (Blinder et al., 2015; Hemker et al., 2011; Kauf et al.,
2009).
Results were interpreted using the odds ratio, which is a relative measure of effect
that allowed the comparison of the intervention group relative to the comparison group.
The confidence interval indicated the level of uncertainty around the measure of effect. I
used a confidence interval (CI) of 95%, which is a common CI used in research studies.
The assumed p value was p < 0.05, which indicated statistical significance between
groups.
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Threats to Validity
External Validity
Data for this study were obtained from a secondary data set from one hospital
system and one comprehensive sickle cell center; therefore, the results are not
generalizable to the total population. I looked at one sickle cell center in the region and
did not look at any other sickle cell centers. Therefore, if patients utilized other EDs in
the region, those visits were not accounted for and the sample was not representative of
the whole population. However, the secondary data were comprehensive and obtained
from multiple years, which provided a thorough analysis of the benefits of one large
sickle cell specialty clinic.
Internal Validity
Errors of misdiagnosis upon presentation to the ED were identified as a threat to
this study’s validity. Furthermore, there was a chance of human error with delayed
documentation, which may have affected the ED LOS. Because sickle cell patients have
multiple complications, mortality was an aspect of this study that may have also affected
the study’s internal validity.
Construct Validity
The accuracy of the data collected in this data set was only as good as the data
entered by the hospital and clinic staff. Simpson et al. (2017) used a similar methodology
of using a pre- and post-enrollment design to assess ED and IP utilization; however, the
study was limited to a small sample and included super-utilizers only. I used similar types
of data associated with a large SCD clinic in one state.
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Ethical Procedures
Permission to access the secondary data set was obtained from the specialty clinic
by completing the CITI training and adding my name to the IRB submission. The data set
was downloaded and stored on my password-protected personal laptop and on a personal
USB drive, and both were stored in a safe when not in use. Furthermore, the laptop that
was used to access the data set was encrypted. Device encryption helped protect the files
and folders from unauthorized access in case the device was stolen. Before analyzing the
data, I transferred the data from Excel to SPSS. The secondary data were de-identified
and did not include the patients’ identifiable information such as the names, dates of
birth, addresses, or social security numbers. Additionally, IRB approval through Walden
University was obtained when the proposal was approved. The approval number from the
Walden IRB was 12-31-20-0735724.
Summary
In Section 2, I described the quantitative methodology for this correlational study.
I used SPSS Version 25, and the population consisted of patients prior to enrollment in
the sickle cell clinic, the post-enrollment group, and their ED utilization. The chosen
analysis was a chi-square test and a paired sample t test, and a linear regression analysis
was used to compare age as a covariate. Section 3 provides the statistical findings relative
to the research questions and associated hypotheses.
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Section 3: Presentation of the Results and Findings
The purpose of this quantitative study was to examine whether there was a
correlation in ED utilization and ED LOS among adult sickle cell patients who received
care at an ER in a major health care system prior to attending the clinic and after
enrollment in the clinic between the years of 2012 and 2017. The study was conducted to
determine administrative benefits of sickle cell centers, demonstrate the need for funding
of sickle cell centers, and encourage evidence-based care for sickle cell patients. The
independent variables were pre-enrollment and post-enrollment to the sickle cell center,
and the dependent variables were ED utilization (the frequency of ED visits), and ED
LOS. The covariate was age of patients.
The research questions and hypotheses were as follows:
RQ1: Is there a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017?
Ho1: There is no statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.
Ha1: There is a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017.
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RQ2: Is there a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017?
Ho2: There is no statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
Ha2: There is a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017.
RQ3: Is there a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho3: There is no correlation between ED utilization and age among adult sickle
cell patients in patients between the years of 2012 and 2017.
Ha3: There is a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
RQ4: Is there a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
Ho4: There is no correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
Ha4: There is a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017.
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This section contains the data collection information of the secondary data set, the
analysis and results of the research questions, and a summary.
Data Collection of Secondary Data Set
The information in section 3 includes the process for the collection of the
secondary data set, how the data were collected, and the time frame of the data collection.
Section 3 also includes the statistical analyses of data from the secondary data set
collected from a sickle cell center. Data were analyzed using a paired sample t test to
analyze the LOS in the pre-enrollment to the clinic group and post-enrollment to the
clinic group. A chi-square analysis was used to analyze the ED utilization, which was a
categorical test to compare the pre- and post-enrollment to the clinic groups. Linear
regression was used to analyze age for both groups. Descriptive statistics included age,
gender, and financial status (which included the type of insurance).
Obtaining Data, Time Frame, and Discrepancies of the Data Set

Obtaining Data
The secondary data set was collected from one sickle cell center located in a
southern U.S. state. This convenience sample data set was obtained to investigate the
effectiveness of an adult sickle cell clinic related to ED utilization and ED LOS.
Permission to access the secondary data set was obtained by completing the CITI
training. After this the data set owners added me to the data set organization’s IRB. After
receiving Walden University’s IRB approval, I analyzed the de-identified data in IBM
SPSS Version 25. The data set included data on all patients with a diagnosis of SCD who
were admitted to the ED in a major hospital system for the time frame of 2012 to 2017.
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Data Filters and Exclusions
The data set consisted of 622 patient pre- and/or post-enrollment to the clinic
encounters. From these 622 encounters, 81 patients were removed from the data set
because they did not have visits in both the pre- and post-enrollment groups. After
removing the 81 patients, I analyzed a total of 412 patient encounters. Furthermore, to
accurately answer Research Question 2 using a paired sample t test, I considered only 37
patients because these patients had matched samples in both the pre-enrollment to the
clinic group and post-enrollment to the clinic group. The clinic group included 210
encounters in the pre-enrollment in an adult sickle cell clinic group and 112 encounters in
the post-enrollment in an adult sickle cell clinic group. Additionally, removing the
encounters with more than 10 ED visits may have provided a more normal distribution
pattern; however, these patient encounters were not removed to provide a true picture of
the ED utilization and ED LOS patterns in the sickle cell population.

Data Filters and Inclusions
The data set consisted of 412 encounters of sickle cell patients and included data
on patients who went to a major hospital’s ED department. All patients considered were
18 years old or older. Data that were analyzed from the data set included the medical
record number, financial number, final classification that included whether the patient
was in a pre- or post-enrollment phase, date of birth, age, gender, race, marital status,
admit type (including emergency, urgent care, or elective), admit date, discharge date,
LOS, and the initial appointment date. The secondary data set for this study included 412
encounters, which was far greater than the G*Power a priori power analysis required
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sample size of 84 (power = 0.80; alpha = 0.05; and predicted moderate effect size = 0.3).
The de-identified data from Excel were imported into IBM SPSS Version 25 for
statistical analysis. The nonnumeric variables were recoded to ensure all data had
numerical values for better analysis.
Descriptive Statistics
The nonnumeric data for admit type were recoded into numbers for more accurate
analysis. Table 2 represents the demographic data including distribution of gender, race,
and marital status. Table 3 includes the distribution of patients in the pre- and postenrollment groups, and Table 4 includes the admit type group (emergency, elective, or
urgent).
Table 2
Descriptive Statistics
Gender
Frequency
Female
Male
Total

183
229
412

Percent
44.4
55.6
100.0

Cumulative
Percent
44.4
100.0

Race
Frequency
Black of African
Amercican
Multiple
Other/ Unknown
Total

Percent

408

99.0

2
2
412

0.5
0.5
100.0

Cumulative
Percent
99.0
99.5
100.0
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Marital Status
Frequency
Divorced
Married
Single
Total

3
79
330
412

Percent
0.7
19.2
80.1
100.0

Cumulative
Percent
0.7
19.9
100.0

Descriptive Statistics
Minimum
Statistics
Age
LOS
Mortality

18
0.564
0.00

Maximum
Statistics
53
29.951
1.00

Mean Statistic
27.63
6.146
0.00243

Std. Deviation
Statistic
7.507
4.086
0.049

As shown in Table 2, 44.4% (n = 183) of the patient encounters were women, and
55.6% (n = 229) of the patient encounters were men. In addition, 99% (n = 408) of the
patient encounters were noted to be Black or African American, 0.5% (n = 2) of the
patient encounters were of multiple races, and 0.5% (n = 2) of the patient encounters
were noted as Other/Unknown. The data were representative of the sickle cell population
where 1 in 400 African Americans and 1 in 19,000 Hispanic individuals have sickle cell
disease (Stone, 2015). Most of the encounters were noted to be single (80.1%), 19.2 %
were married, and 0.7% were divorced.
The descriptive statistics indicated that the mean age of the total
encounters was 27.63 years, with a minimum age of 18 years and a maximum age of 53
years. The mean LOS in the ED was noted to be 6.146 hours, with a minimum of 0.564
hours and a maximum of 29.951 hours. The mean mortality rate was 0.002 encounters
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with a minimum mortality of 0 encounters and a maximum of 1 encounter. Table 3
includes the distribution of patients in the pre- and post-enrollment groups, and Table 4
includes the admit type group (emergency, elective, or urgent).
Table 2
Pre-Enrollment to Clinic and Post-Enrollment to Clinic
Frequency
Post-enrollment
Pre-enrollment

197
215

Percent

Cumulative percent
47.8
100.0

Percent

Cumulative percent
4.1
73.3
73,5
100.0

47.8
52.2

Table 3
Types of Patient Admissions
Frequency
Elective
Emergency
Newborn
Urgent
Total

17
285
1
109
412

4.1
69.2
0.2
26.5
100.0

Table 3 indicates the distribution of patients in the before enrollment to the clinic
(pre-enrollment group) and after enrollment to the clinic (post-enrollment group). Table 4
includes the distribution in the admit type group (emergency, elective, or urgent). Table 3
shows that 47.8% (n = 197) of the patient encounters were categorized in the postenrollment group, and 52.2% (n = 215) of the patient encounters were categorized in the
pre-enrollment group. In addition, the data set was categorized into 4.1% (n = 17) of the
encounters in the elective admission type, 69.2% (n = 285) of the encounters in the
emergency admission type, 0.2% (n = 1) of the encounters in the newborn admission
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type, and 26.5% (n = 109) of the encounters in the urgent care admission type. The data
showed that only 285 encounters were related to ED utilization.
Study Results
After completing the collection, organization, and description of the secondary
data set, I used inferential statistics to test the hypotheses of the research questions. The
inferential statistics tests that were used included the chi-square test of association and
the paired sample t test. Research Question 1 was answered using the chi-square test of
association, and Research Question 2 was answered using a paired sample t test.
Research Question 1
RQ1: Is there a statistically significant difference in ED utilization among adult
sickle cell patients before enrollment in an adult sickle cell clinic and after enrollment
between the years of 2012 and 2017?
To answer this research question, the chi-square test was used. A chi-square test is
nonparametric test to examine a possible association between two nominal variables
(Allwright, 2019). This test allows a researcher to evaluate the association, interpret the
chi-square, and interpret the strength of the association (Allwright, 2019). A chi-square
association has no more than 20% of the expected counts as less than 5. When expected
counts are equal to or close to the observed count, there is no relationship between the
variables; when the alpha p value is less than 0.05, the results are considered significant,
the null hypothesis can be rejected, and the alternative hypothesis can be accepted
(Allwright, 2019). Mchugh (2013) reported the following assumptions for use of the chisquare test: The data should be frequencies or counts and not percentages, and the levels
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of the variables should be mutually exclusive. In the current study, both the independent
and dependent variables were nominal levels of data. The dependent variables were ED
utilization and ED LOS, and the independent variables were pre-enrollment to the clinic
and post-enrollment to the adult sickle cell center. The ED utilization was counted in
frequencies (1 for an ED visit and 0 for any other visit). Each encounter was mutually
exclusive, where each encounter could not be in both the pre-enrollment to the clinic
group and post-enrollment to the clinic group.
A chi-square test was chosen for Research Question 1 because the data were
collected as encounters and the variables were mutually exclusive. A patient encounter
could not be in the pre-enrollment and post-enrollment group at the same point in time,
and the dependent variable was nominal. The independent variable in the research
question was pre-enrollment to the clinic or post-enrollment to the clinic. The dependent
variable was whether the patients utilized the ED or not. Table 5 shows the crosstabulation, Table 6 shows the chi-square tests that were used, Table 7 shows the
correlation test, and Table 8 shows the odds’ ratio (OR). Figure 3 shows the frequency of
ED utilization in the pre-enrollment to the clinic group and post-enrollment to the clinic
group.
The results of the chi-square test showed that there was a statistically significant
difference in ED utilization among adult sickle cell patients before enrollment in an adult
sickle cell clinic and after enrollment between the years of 2012 and 2017 (chi-square =
13.612a, df = 1, p < 0.05). The alpha value was noted to be .000, which was less than p
value of .05, and therefore the null hypothesis was rejected and the alternate hypothesis
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was accepted. The Pearson chi-square test was used to analyze the data because the
expected counts in the pre-enrollment to the clinic, post-enrollment to the clinic, nonemergency admit types, and ED utilization groups were all greater than 5.
To analyze the strength of the correlation, the Cramer’s V test was used. The
Cramer’s V value was noted to be RR= 0.182, which is RR < 1, so there was a negative
association between post-enrollment and ED utilization; however, the effect size was
small or weak. Additionally, the OR = 2.221 (95% CI: 1.448, 3.406) suggesting that the
counts in the post-enrollment group were 2.221 times more likely to use the
nonemergency admit types, and less likely to use the emergency admit type.
The cross-tabulation table shows that in the post-enrollment group 39.6% of the
counts were categorized in the nonemergency admit types, which included having an
admit type of anything other than the emergency room, and 60.4% of the post-enrollment
counts were categorized as having an emergency admit type. Alternatively, in the before
registration to the clinic group, 22.8% of the counts were categorized in the
nonemergency admit types, and 77.2% of the counts belonged in the emergency group.
Figure 3 illustrates how the ED utilization in the post-enrollment group was lower than
the pre-enrollment group; however, the nonemergency admit types category was higher
in the post-enrollment group compared to the pre-enrollment group. The results indicated
an increased use of other admit types such as elective admissions and/or urgent care
admissions instead of ED utilization.
For RQ1, the null hypothesis was rejected, and the alternate hypothesis was
accepted. There was a statistically significant difference in ED utilization among adult
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sickle cell patients in the pre-enrollment group and the post-enrollment group, with the
OR and cross-tabulation findings showing ED utilization was less in the post-enrollment
group. Table 5 shows the cross-tabulation table for ED utilization in the pre-enrollment to
clinic group and post-enrollment to clinic group. Table 6 includes the Chi-square analysis
comparing ED utilization in the pre-enrollment and post-enrollment to clinic, and table 7
and 8 includes the test of correlation of strength and the odds ratio for the chi- square
analysis.
Table 4
Final Classification Emergency Utilization Cross-Tabulation

Final
Post-enrollment
Classification

Pre-enrollment

Total

Count
Expected Count
% within Final
classification
Count
Expected Count
% within Final
classification
Count
Expected Count
% within Final
classification

Non
emergency
admit types Emergency
78
119
60.7
136.3
39.6%
60.4%

Total
197
197.0
100.0%

49
66.3
22.8%

166
148.7
77.2%

215
215.0
100.0%

127
127.0
30.8%

285
285.0
69.2%

412
412.0
100.0%
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Table 5
Chi-Square Tests for Association of Pre and Post-Enrollment to Sickle Cell Clinic and
ED Utilization

Value
13.612a
12.836

Asymptotic
Significance Exact Sig. (2- Exact Sig. (1df
(2-sided)
sided)
sided)
1
.000
1
.000

Pearson Chi-Square
Continuity
Correctionb
Likelihood Ratio
13.681
1
.000
Fisher’s Exact Test
.000
.000
N of Valid Cases
412
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 60.73.
b. Computed only for a 2x2 table
Table 6
Test of Correlation for Strength of Association From Chi-Square Test

Nominal by
Nominal

Phi
Cramer’s
V

Approximate
Value
Significance
.182
.000
.182
.000

N of Valid Cases
412
c. Correlation statistics are available for numeric data
only.
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Table 7
Odd’s Ratio for Likeliness of Using the ED

Odds Ratio for Final Classification (Postenrollment/ Pre-enrollment)
For cohort Non-emergency admit types

Value
2.221

95% Confidence Interval
Lower
Upper
1.448
3.406

1.737

1.286

2.346

For cohort Emergency Utilization

.782

.684

.895

N of Valid Cases

412
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Figure 3
ED Utilization in Pre- and Post-Enrollment to the Clinic Groups

Research Question 2
RQ2: Is there a statistically significant difference in ED length of stay among
adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment between the years of 2012 and 2017?
A paired t-test is used to compare two population means where you have two
samples where observations in one sample can be paired with observations in the other
sample (Walden University Academic Skills, 2020). The paired t test provides a
hypothesis test of the difference between population means for a pair of random samples
whose differences are approximately normally distributed (Walden University Academic
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Skills, 2020). Statistical assumptions of the paired sample t-test include that the
dependent variable should be a continuous variable; independent variables should consist
of two categorical and related or matched groups; there should be no significant outliers
and the groups should be normally distributed (Walden University Academic Skills,
2020). The dependent variable is the ED LOS, which is a continuous variable, and the
independent variable is the pre-enrollment and post-enrollment groups, which are
nominal variables. The data set however was not normally distributed and will be
described in detail later in the study.
A paired sample t-test was used for research question 2 because the dependent
variable (length of stay: LOS) is a continuous variable, and the independent variable is
categorical and related (before enrollment to the clinic and after enrollment to the clinic).
All the patients in this list were counted in both the pre-enrollment group or the postenrollment group. To create a paired sample, a total of 37 patients were used for this
dataset, which looked at 210 encounters in the before registration to the clinic group, and
112 encounters in the after registration to the clinic group. Since the sample size was
greater than 20, a paired sample t-test was still used instead of the non-parametric test. To
meet the assumption of using a paired sample t-test, the data had to be normally
distributed. Figure 3 is a side-by-side bar graph that demonstrates the distribution of ED
LOS in the pre-enrollment to clinic group compared to the distribution of ED LOS in the
post-enrollment to clinic group. The standard error of skewness was 0.388, which is less
than 0.5, which indicates the data is normally distributed.

46
The findings of the paired sample t-test demonstrates that the mean ED LOS of
the pre-enrollment group, m = 28.01 hours, was higher than the mean ED LOS of the
post-enrollment group, m = 19.45 hours. The mean difference between the before clinic
enrollment ED LOS group and the after-clinic enrollment ED LOS group was m = 8.560,
95% CI (6.904, 24.024). Furthermore, p=.269 is p > .05, therefore the null hypothesis is
accepted and the alternate hypothesis is rejected indicating that there was no statistically
significant difference in ED length of stay among adult sickle cell patients before
enrollment in an adult sickle cell clinic and after enrollment between the years of 2012
and 2017.
A two-tailed paired sample t-test revealed that ED LOS in the pre-enrollment to
clinic group (m = 28.01) was not significantly different than the ED LOS in the postenrollment to clinic group (m = 19.45), t (36) = 1.123, p < 0.05). The results of this study
shows no strong evidence to suggest a statistically significant difference in ED LOS
among adult sickle cell patients before enrollment in an adult sickle cell clinic and after
enrollment in an adult sickle cell clinic (t = 11.123, df = 36, p > .05, 2 tailed test).
However, it is important to note that although no significant difference was noted, the
mean LOS of post-enrollment to the clinic was noted to be less than the mean LOS of the
pre-enrollment to the clinic group. Table 10 represents the Means table of the paired
sample t-test, and table 11 represents the findings of the paired t-test.
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Figure 4
ED LOS in the Pre-Enrollment to Clinic and Post-Enrollment to Clinic Group

The mean ED LOS in the pre-enrollment group is 28.01 hours and the mean ED LOS in
the post-enrollment group is 19.45 hours. Table 9 and 10 includes the means table for the
paired sample t-test comparing ED LOS in the pre-enrollment and post-enrollment to the
clinic groups, and the results of the paired sample t-test.
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Table 8
Means Table for Paired Sample t Test of ED LOS in Pre-Enrollment and PostEnrollment Groups

Pair 1

Preenrollment
LOS
Postenrollment
LOS

Mean
28.01

19.45

N
37

Std. Deviation Std. Error Mean
40.812
6.709

37

28.798

4.734

Table 9
Paired Samples t Test for ED LOS in the Pre-Enrollment and Post-Enrollment Groups

Pair 1 PreEnrolEDLOS –
PostEnrolEDLOS

Paired Differences
95% Confidence
Std.
Std.
Interval of the
Deviatio Error
Difference
Mean
n
Mean Lower Upper
t
8.560
46.381 7.625 -6.904
24.024 11.123

df
36

Research Question 3
RQ3: Is there a correlation between ED utilization and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
To analyze this research question, a linear regression analysis was used. To
examine if there was a correlation in ED utilization and age, a linear regression analysis
was used. The independent variable was age and the dependent variable was ED

Sig. (2tailed)
.269
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utilization. Table 12 shows the Model summary table of ED utilization and age. The Rvalue is the multiple correlation coefficient and has a value of 0.120, indicating a small
level of prediction. The R square is the coefficient of determinization, and represents the
proportion of variance in the dependent variable (ED utilization) that can be explained by
the independent variables (age). The R square value is 0.014, indicating that age explains
1.4% of the variability of ED utilization. Table 13 shows the ANOVA table of ED
utilization with age. Table 13 shows whether the overall regression model is a good fit for
the data. The table shows that the independent variables statistically significantly predict
the dependent variable, F(1,410)= 6.012, p<.05, R square = 0.014, indicating this model
is a good fit of the data. Table 14 shows the coefficient table of ED utilization with age
indicating how much the ED utilization varies with an independent variable (age) when
all other independent variables are held constant. The coefficient table shows us that the
coefficient for age is equal to -.007, indicating that for each one-year increase in age,
there is a decrease in ED utilization of 0.007 hours, where p<.05.
Therefore, the statistical analysis for RQ3 accepts the alternate hypothesis that
there is a correlation between age and ED utilization, where an increased age decreases
ED utilization. Research question 1 also accepted the hypothesis that there was a
significant difference in ED utilization in the pre-enrollment to clinic group and postenrollment to clinic group, with less ED utilization noted in the post-enrollment to the
clinic group. Since the patients in the pre-enrollment group were also examined in the
post-enrollment group, the patients in the post-enrollment group would be naturally older
due to maturity. Using the findings from the linear regression, where 1.4% of the
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variability in the ED utilization may have been related to age, which may have impacted
the significant difference in ED utilization with pre/post-enrollment to clinic findings.
Table 10
Model Summary for ED Utilization and Age

Adjusted R Std. Error of
Square
the Estimate
.012
.460

Model
R
R Square
a
1
.120
.014
a. Predictors: (Constant), AGE
b. Dependent Variable: CODED_EMERGENCY_UTIL

Table 11
Coefficient Table for ED Utilization and Age
Unstandardized
Standardized
Coefficients
Coefficients
Std. Error
Beta
B
.086
.896

t
Sig.
10.36
.000
9
.003
-.120 -2.452
.015
-.007
a. Dependent Variable: CODED_EMERGENCY_UTIL
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Table 12
ANOVA Table for ED Utilization and Age

Sum of
Mean
Model
Squares
Df
Square
F
1
Regression
1.270
1
1.270 6.012
Residual
86.582
410
.211
Total
87.852
411
a. Dependent Variable: CODED_EMERGENCY_UTIL
b. Predictors: (Constant), AGE

Sig.
.015b

Research Question 4
RQ4: Is there a correlation between ED LOS and age among adult sickle cell
patients in patients between the years of 2012 and 2017?
To analyze this research question, another linear regression analysis was used.
The independent variable was age and the dependent variable was ED utilization. Table
15 shows the Model summary table of ED LOS and age. The R-value is the multiple
correlation coefficient and has a value of 0.093, indicating a very small level of
prediction. The R square value is 0.009, indicating that age explains 0.09% of the
variability of LOS. Table 16 shows the ANOVA table of ED LOS with age. The table
shows that the independent variable does not statistically significantly predict the
dependent variable, F(1,410) = 3.592, p>0.05, R square = 0.009, indicating this model is
not a good fit of the data. Table 17 shows the coefficient table of ED LOS with age
indicating how much the ED LOS varies with an independent variable (age) when all
other independent variables are held constant. The coefficient table shows us that the
coefficient for age is equal to -.053, indicating that for each one-year increase in age,
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there is a decrease in ED LOS of 0.053 hours, where p>.05, and therefore no statistical
significance is noted.
Therefore, the statistical analysis for RQ4 accepts the null hypothesis that there is
no correlation between age and ED LOS. Research question 2 also accepted the null
hypothesis that there was no significant difference in ED LOS in the pre-enrollment to
clinic group and post-enrollment to clinic group. Using the findings from the linear
regression and the paired sample t-test, ED LOS was not correlated to age, nor enrollment
to a sickle cell clinic.
Table 13
Model Summary for ED LOS and Age

Model

R
.093a

1

R Square
.009

Adjusted R Std. Error of
Square
the Estimate
.006 4.245856314
784

a. Predictors: (Constant), AGE
b. Dependent Variable: LOS_ED_ONLY

Table 14
ANOVA Test for ED LOS and Age

Model
1

Sum of Squares
Regression

df

Mean Square

64.747

1

64.747

Residual

7391.191

410

18.027

Total

7455.938

411

a. Dependent Variable: LOS_ED_ONLY
b. Predictors: (Constant), AGE

F
3.592

Sig.
.059b
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Table 15
Coefficient Table for ED LOS and Age

Unstandardized
Coefficients
Model
1

(Constant)
AGE

Standardized
Coefficients

B
Std. Error
5.723
.799
-.053
.028

Beta

T
Sig.
7.166 .000
-.093
- .059
1.895

95.0% Confidence
Interval for B
Lower
Upper
Bound
Bound
4.153
7.293
-.108
.002

a. Dependent Variable: LOS_ED_ONLY

Conclusion
In section 3, I presented the results and findings of this study, including the data
collection plan, data exclusion, data inclusions, descriptive statistics, and inferential
statistics. The inferential statistics that were used included cross-tabulations with Chisquare test of association and effect size using the Cramer’s V test for research question
1; and a paired sample t-test to answer research question 2.
Research question 1 (RQ1) answered the question: Is there a statistically
significant difference in ED utilization among adult sickle cell patients before enrollment
in an adult sickle cell clinic and after enrollment between the years of 2012 and 2017?
The results from the Chi square analysis found that the null hypothesis was accepted. The
results of the Cramer’s V association and the Odds ratio noted a statistically significant
association with ED utilization between pre and post-enrollment to the SCD clinic,
indicating that after enrollment to the clinic the patients had less ED utilization.
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Therefore, the null hypothesis for HO1 was rejected and the alternative hypothesis was
accepted.
Research question 2 (RQ2) answered the question: Is there a statistically
significant difference in ED length of stay among adult sickle cell patients before
enrollment in an adult sickle cell clinic and after enrollment between the years of 2012
and 2017? The results of the paired sample t-test found that there was no significant
difference in ED LOS in the pre-enrollment to the sickle cell clinic group and the postenrollment to the sickle cell clinic group. Therefore, the RQ2 results accepted the null
hypothesis. Although no statistical significance was noted in both groups, the means table
from the paired sample t-test did show a higher mean LOS in the before clinic enrollment
group compared to the after-clinic enrollment group.
Research question 3 (RQ3) answered the question: Is there a correlation in ED
utilization and age among adult sickle cell patients? The results of the linear regression
analysis found that there was a significant correlation in ED utilization and age in adult
sickle cell patients. Therefore, the RQ3 rejected the null hypothesis and accepted the
alternate hypothesis.
Research question 4 (RQ4) answered the question: Is there a correlation in ED
LOS and age among adult sickle cell patients? The results of the linear regression
analysis found that there was no significant correlation in ED LOS and age in adult sickle
cell patients. Therefore, the RQ4 accepted the null hypothesis. Section 4 includes the
interpretation of the results, limitations of the study, recommendations, and implications
for professional practice.
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Section 4: Application to Professional Practice and Implications for Social Change
The purpose of this quantitative study was to examine the correlation in ED
utilization and ED LOS among adult sickle cell patients who received care at an adult
comprehensive sickle cell clinic pre- and post-enrollment to the center between the years
of 2012 and 2017. Findings from the chi-square test showed that there was a statistically
significant difference in ED utilization among adult sickle cell patients before enrollment
in an adult sickle cell clinic and after enrollment, with a trend to have decreased ED
utilization post-enrollment. The findings from the paired sample t test showed that there
was no statistically significant difference in ED LOS among sickle cell patients before
enrollment in an adult sickle cell clinic and after enrollment. However, the mean ED LOS
in the pre-enrollment group was greater than the mean ED LOS in the post-enrollment
group. The results indicated that when SCD patients were enrolled in a comprehensive
sickle cell center, their ED use was decreased significantly, which indicated improvement
in patient care and a decrease in overall cost of care related to unnecessary ED utilization.
The results of this study demonstrated that there are administrative benefits, such
as decreased ED utilization and possible decreased EDLOS, for patients attending
comprehensive sickle cell clinics. Decreased ED utilization can decrease unnecessary
costs by decreasing duplication of services and improve quality of care (Ho et al., 2017).
It is in the best interest of hospital administrators to pay careful attention to ED
optimization to improve performance and quality measures (Feinberg & Stone-Griffith,
2016). Feinberg and Stone-Griffith (2016) stated that hospitals are under regulatory
pressure to reduce ED costs, improve efficiency, and increase throughput capacity, which
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then ties to hospital reimbursement. Section 4 contains the interpretation of the findings,
the limitations of this study, recommendations, the implications for professional practice
and social change, and a conclusion.
Sickle Cell Centers
Fragmented care is a problem for all patients, but for fragile and complicated
illnesses like sickle cell disease, fragmented care can result in poor outcomes and
decreased quality of life due to frequent flair-ups and chronic pain (Blinder et al., 2015;
Koch et al., 2014; Ter-Minassian et al., 2019). Simpson et al. (2017) and Powell et al.
(2016) provided information on how a multidisciplinary approach affects ED utilization
in the sickle cell population. The researchers found that monthly meetings, best practice
advisories, and ED protocols helped to decrease ED visits, ED LOS, IP admissions, and
IP LOS. The practice of monthly meetings, individualized pain plans for ED protocols,
and best practice advisories are consistent with comprehensive sickle cell clinics’
practices.
Adult sickle cell centers use a multidisciplinary approach of care, and Powell et
al. (2016) and Simpson et al. (2017) reported that this improves overall outcomes and
strengthens relationships with a medical practice that understands best practices for this
condition. When there is a lack of sickle cell providers, patients with SCD tend to utilize
ED services more than clinic services due to untreated pain and other symptoms (Blinder
et al., 2015). The current study focused on a large, comprehensive sickle cell clinic
associated with a teaching center to examine the association between ED utilization and
ED LOS.
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Interpretation of Results
RQ 1 Analysis
RQ1 asked the following: Is there a statistically significant difference in ED
utilization among adult sickle cell patients before enrollment in an adult sickle cell clinic
and after enrollment between the years of 2012 and 2017? The results indicated that there
was a statistically significant difference in ED utilization in the pre-enrollment group and
post-enrollment group, where the ED utilization was higher in the pre-enrollment group
compared to the post-enrollment group. A chi-square test was used to analyze the data. A
categorical value of 0 was used for nonemergency utilization, and 1 was used for
emergency utilization. The alpha value was noted to be .000, which is less than p value of
.05. Therefore, Ho1was rejected and Ha1was accepted. To assess the type of correlation
between the groups, the Cramer’s V test was used. The Cramer’s V value was noted to be
RR= 0.182, where RR < 1, which indicated a negative association between postenrollment and ED utilization; however, the effect size was small or weak. The odd’s
ratio suggested that the counts in the post-enrollment group were 2.221 times more likely
to use the nonemergency admit types, and less likely to use the Emergency admit type
(OR = 2.221, 95% CI: 1.448, 3.406).
RQ2 Analysis
RQ2 asked the following: Is there a statistically significant difference in ED
length of stay among adult sickle cell patients before enrollment in an adult sickle cell
clinic and after enrollment between the years of 2012 and 2017? The results indicated
that there was no statistically significant difference in ED LOS in the pre-enrollment and
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post-enrollment groups. The test used here was a paired sample t test to assess two scale
variables: the pre-enrollment to the clinic LOS and the post-enrollment to the clinic LOS
within the same sample group. The findings of the paired sample t test indicated that the
mean ED LOS of the pre-enrollment to clinic group, m = 28.01 hours, was higher than
the mean ED LOS of the post-enrollment to clinic group, m = 19.45 hours. The mean
difference between the before registration to clinic group and the after registration to
clinic ED LOS group was m = 8.560, 95% CI (6.904, 24.024). However, p = .269 was p >
.05; therefore, the null hypothesis was accepted, and the alternate hypothesis was
rejected. The mean ED LOS in the post-enrollment group was less than the ED LOS in
the pre-enrollment group. The results indicated that although there was no significant
difference in ED LOS in the two groups, there was still a tendency to have a lower LOS
in the post-enrollment clinic group compared to the pre-enrollment group.
RQ3 Analysis
RQ3 asked the following: Is there a correlation between ED utilization and age
among adult sickle cell patients in patients between the years of 2012 and 2017? The
results indicated that there was a significant correlation between ED utilization and age in
these adult sickle cell patients. A linear regression analysis was used to analyze these
data. The linear regression was run to predict ED utilization from age. Age statistically
significantly predicted ED utilization, F(1,410)= 6.012, p < .05, R square = 0.014,
indicating age added statistically significantly to the prediction of ED utilization, p <
0.05. R square of 0.014 indicated that 1.4% of the variability in ED utilization was due to
age.
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RQ4 Analysis
RQ4 asked the following: Is there a correlation between ED LOS and age among
adult sickle cell patients in patients between the years of 2012 and 2017? The results
indicated that there was no significant correlation between ED LOS and age in these adult
sickle cell patients. A linear regression analysis was used to analyze these findings. Age
did not statistically significantly predict ED LOS, F(1,410)= 3.592, p > 0.05, R square =
0.009, indicating age did not statistically significantly predict ED LOS, p > 0.05.
Interpretation of Findings to Literature
I investigated the correlation in ED utilization and ED LOS with SCD patients
before they were enrolled in a sickle cell center compared to SCD patients after they were
enrolled in the sickle cell clinic. The findings indicated that there was a statistically
significant difference in ED utilization among adult sickle cell patients before enrollment
in an adult sickle cell clinic and after enrollment between the years of 2012 and 2017
with ED utilization higher in the pre-enrollment group. The findings also indicated that
there was no statistical difference in ED LOS among adults before or after enrollment to
the sickle cell clinic. The literature review demonstrated the correlation between
comprehensive sickle cell centers and ED utilization/ED LOS was mixed, with some
studies suggesting increased ED utilization (Carden et al., 2016; Lavelle et al., 2018;
Smeltzer et al., 2016) and some studies suggesting decreased ED utilization (Powell et
al., 2016; Simpson et al., 2017).
Previous studies showed that a multidisciplinary approach to SCD care reduced
the ED utilization and ED LOS (Powell et al., 2016; Simpson et al., 2017). Simpson et al.
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(2017) found that using a targeted approach of patient-specific best practice advisories,
an ED management protocol, and the formation of a medical home for high-utilizer sickle
cell patients decreased ED utilization, decreased ED LOS, and decreased inpatient
utilization. Simpson et al. (2017) used a pre-post design but only looked at confidence
intervals, not statistical significance.
Additionally, Blinder et al. (2015) found that ED reliance increased in the
transition-age group due to decreased access to primary care providers and decreased
engagement with SCD patients. The findings of the current study aligned with previous
multidisciplinary approaches and that utilizing best practice guidelines can help with
reducing unnecessary ED utilization. However, no significant differences were noted in
ED LOS. However, it is worthy to note that the mean LOS in the after enrollment to the
sickle cell clinic was lower than the mean LOS in the before enrollment to the sickle cell
clinic group.
Blinder et al. (2014) found that age and disease severity increased ED utilization.
Blinder et al. found that between the age of 15 years and 22 years, ED reliance increased
from 0.17 to 0.29 visits per quarter and remained high throughout adulthood. These
findings are consistent with findings from the current study, which indicated that age
increased ED utilization.
Interpretation of Findings to Theory
The conceptual framework for this study was the Donabedian framework. The
Donabedian framework includes three categories: structure, process, and outcome
(Donabedian, 1985). The structure consists of how care is organized, the process consists
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of what is known to be the best evidence-based medicine, and the outcome is the quality
measure that affects the result of care (Donabedian, 1985; Van Houdt et al., 2013). In the
current study, the structure was the comprehensive sickle cell clinic; the process was the
best practice standards already researched in sickle cell, which included multidisciplinary
care and individualized care plans; and the outcome was the use of ED utilization and
LOS in the ED. The findings from this study indicated that organized care at a
comprehensive sickle cell clinic can improve patient outcomes such as ED utilization (see
Figure 4). Although the ED LOS did not show a significant difference between the preenrollment group and post-enrollment group, there was a trend of shorter ED LOS in the
post-enrollment group. Future studies with a larger sample for the paired sample t test
should be considered.
Summary of Key Findings and Interpretations
The results of this study indicated that there was a statistically significant
difference in ED utilization in the same group of adult sickle cell patients prior to
enrollment in an adult sickle cell center and post-enrollment to the center, but no
significant difference in the ED LOS in a paired sample of adult sickle cell patients was
noted. The findings suggested that the ED utilization was significantly less in the SCD
patients who were enrolled to the sickle cell clinic. Additionally, the findings also
showed no significant differences in ED LOS in SCD patients before or after being
enrolled in the sickle cell clinic. The results suggest the administrative benefits for
patients who attend comprehensive sickle cell centers. Unnecessary ED utilization in the
United States can be managed in physician offices and clinics at a savings of $4.4 billion
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annually (Enard & Ganelin, 2014). Enard and Ganelin (2014) also reported that
unnecessary ED utilization can lead to decreased efficiency of the hospital and the
possibility for more uncompensated care. The current study provided additional evidence
to support the development of more adult sickle cell clinics.
Limitations of the Study
The first limitation was a secondary data set was used to address the research
questions. Using a secondary data set limits the generalizability of the results. Although
this data set included a large sample size of 622 patient encounters, this data set included
data from only one sickle cell clinic. The sickle cell clinic was in one state, which limited
generalizability to all SCD patients and specialty clinics. Additionally, the data set
included ED utilization and ED LOS data in only one major health care system rather
than all of the health care systems in the area. Therefore, if a patient utilized another
hospital system’s health care ED, these data were not included. I assumed that the SCD
patient would go to the health care system that the patient considered their medical home.
Also, the data set included data from the time period of 2012 until 2017 rather than more
recent data.
Recommendations
The limitations of the study indicated opportunities for future research. Future
studies with data in a more current time frame and observing data for a longer period of
time would be beneficial to understand changes that occur over time. It would also be
advantageous to expand the study to multiple states/regions and to utilize data from
multiple sickle cell centers. Researching more diverse populations may allow the results
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to be more generalizable. Examining the cost-of-care data with each ED encounter could
also reveal the potential savings that a sickle cell center could bring to a health care
system.
Implications for Professional Practice and Social Change
The results of this study were intended to provide information for professional
practice and social change relevant to the administrative benefits of sickle cell centers.
The results of this study showed the administrative benefits of adult sickle cell patients
attending a comprehensive sickle cell center, including significant decreased ED
utilization and possible decreased ED LOS. The study could encourage primary care
providers, pediatric sickle cell centers, and hematologists to transfer the care of adult
sickle cell patients to adult sickle cell centers. The results could also encourage the adult
sickle cell centers to use a multidisciplinary approach, best practice advisories, ED
protocols, and a framework for treating adult patients with SCD. Additionally, this study
could help administrators understand the potential savings on health care costs from these
reduced ED visits, improved efficiency, and reduced ED LOS. The findings of this study
may contribute to positive social change by policymakers and administrators
understanding the benefits of SCD centers and investing in more SCD centers in health
care systems.
Conclusion
The study addressed the gap in the literature regarding the administrative benefits
of adult sickle cell centers. My findings indicated that there was a significant reduction in
ED utilization among adult sickle cell patients after enrollment in an adult sickle cell
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center. Based on the findings of this study, hospital administrators and other providers
may recognize the value of sickle cell centers. Hospital administrators may embrace the
findings in support of sickle cell centers not only for improved patient outcomes but also
for potential cost reduction.
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